Companies similar to ZYMEWORKS INC (ZYME)
Health Care · NASDAQ
ZYMEWORKS INC (ZYME)'s closest peers include Amgen (AMGN), Regeneron Pharmaceuticals (REGN), Incyte (INCY), Alnylam Pharmaceuticals (ALNY) and ADC THERAPEUTICS SA (ADCT). This peer set is drawn from ZYME's enriched company profile and is informational only — not financial advice.
Similar companies
-
AmgenAMGNHealth Care
A global biotechnology innovator producing biologics, monoclonal antibodies, and small molecules across oncology, cardiovascular, inflammation, and bone…
$371.58 (as of 2026-07-16) · market cap $196.8B
-
Regeneron PharmaceuticalsREGNHealth Care
Regeneron develops and commercializes monoclonal antibody and other biologics therapies across immunology, oncology, infectious disease, and other therapeutic…
$678.94 (as of 2026-07-16) · market cap $70.5B
-
IncyteINCYHealth Care
A biopharmaceutical company pioneering targeted therapies for blood cancers and inflammatory diseases, with flagship JAK inhibitor JAKAFI generating…
$116.65 (as of 2026-07-16) · market cap $23.2B
-
Alnylam PharmaceuticalsALNYHealth Care
A commercial-stage RNAi therapeutics pioneer with six FDA-approved siRNA medicines targeting rare genetic and cardiometabolic diseases.
$283.15 (as of 2026-07-16) · market cap $37.2B
-
ADC THERAPEUTICS SAADCTHealth Care
ADC Therapeutics develops antibody-drug conjugates (ADCs) targeting hematologic and solid tumors, with its lead product ZYNLONTA commercialized for lymphoma.
$1.35 (as of 2026-07-16) · market cap $172M
Not quite? Describe exactly what you want →
Peers are drawn from ZYME's enriched profile (the same similarity signal the chat uses for "companies like ZYME"). See the full profile: ZYMEWORKS INC (ZYME).
Last updated 2026-07-16.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.